Skip to main content

Table 1 Molecular structures of arylimidamide-azole hybrids, and pentamidine with their anti-leishmanial activities and MolDock scores

From: A combined 2-D and 3-D QSAR modeling, molecular docking study, design, and pharmacokinetic profiling of some arylimidamide-azole hybrids as superior L. donovani inhibitors

  1. IC50-half-maximal inhibitory concentration, pIC50-negative log of IC50